Halyna Voskoboinikova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Halyna Voskoboinikova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Viktoria Dovzhuk
Bogomolets National Medical University
4 shared publications - Natela Dovzhuk
Bogomolets National Medical University
3 shared publications - Людмила Володимирівна Коновалова
Національний медичний університет імені О. О. Богомольця
3 shared publications - Ye. P. Boguslavskyi
Київський національний університет технологій та дизайну
2 shared publications - Andriy Goy
Київський національний університет технологій та дизайну, АТ «Фармак
1 shared publication Iryna Vakulyk
National University of Life and Environmental Sciences of Ukraine, Ukraine
1 shared publication
Latest Publications
- Open Access
- 30 June 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 3 (49),p. 86-95
Study of the identity of the polymorphic form of API – dapagliflosin derivative and of its permanency structure under the influence of the tableting process
The aim. To investigate the polymorphic structure of the API – Dapagliflozin propanediol monohydrate and to reveal the absence of an effect of the tabletting process on the polymorphic structure of the API in model compositions of tablets. Materials and methods. Model mixtures of API - dapagliflozin propanediol monohydrate and excipients were studied. The research used the method of designing pharmaco-technological parameters of solid dosage forms, the method of quantum-chemical modelling of the mechanical properties of polymorphic modifications of APIs, the modelling of shear deformation, the nanoindentation method, the Rietveld method for calculating X-ray patterns, X-ray structural analysis of API and selected model compositions of tablets. Results. The polymorphic structure of API - dapagliflozin propanediol monohydrate and its polymorphic structure in selected model compositions of tablets produced by the pressing method were studied and analyzed. An X-ray structural study was carried out, and the qualitative and phase composition of samples and polymorphic modifications of API and model series of tablets were determined. According to the results of the X-ray structural analysis, it was established that there is no polymorphic transition and that the polymorphic structure of API is invariant under the influence of pressing pressure, which ensures the quality of the tablet form. Conclusions. The design of an experimental study was determined based on the application of the QbD concept, design of experiments – DoE, for designing and ensuring a high-quality technological process – tabletting of API - Dapagliflozin propanediol monohydrate and excipients. To manage a critical technological parameter - the stability of the polymorphic structure of the API, which guarantees the quality of the tablet form, its bioavailability and bioequivalence, it is necessary to use a set of methods for studying structural changes and polymorphic modifications of the API during the tableting process. According to the results of the X-ray structural study of API and selected model compositions of tablets, it was established that during the process of tabletting under pressure, the structure of the polymorphic modification of dapagliflozin propanediol monohydrate does not change, and no polymorphic transition is observed
- 30 June 2024
- Published by Private Company Technology Center in ScienceRise: Pharmaceutical Science
- No. 3 (49),p. 86-95
Open AccessStudy of the identity of the polymorphic form of API – dapagliflosin derivative and of its permanency structure under the influence of the tableting process
The aim. To investigate the polymorphic structure of the API – Dapagliflozin propanediol monohydrate and to reveal the absence of an effect of the tabletting process on the polymorphic structure of the API in model compositions of tablets. Materials and methods. Model mixtures of API - dapagliflozin propanediol monohydrate and excipients were studied. The research used the method of designing pharmaco-technological parameters of solid dosage forms, the method of quantum-chemical modelling of the mechanical properties of polymorphic modifications of APIs, the modelling of shear deformation, the nanoindentation method, the Rietveld method for calculating X-ray patterns, X-ray structural analysis of API and selected model compositions of tablets. Results. The polymorphic structure of API - dapagliflozin propanediol monohydrate and its polymorphic structure in selected model compositions of tablets produced by the pressing method were studied and analyzed. An X-ray structural study was carried out, and the qualitative and phase composition of samples and polymorphic modifications of API and model series of tablets were determined. According to the results of the X-ray structural analysis, it was established that there is no polymorphic transition and that the polymorphic structure of API is invariant under the influence of pressing pressure, which ensures the quality of the tablet form. Conclusions. The design of an experimental study was determined based on the application of the QbD concept, design of experiments – DoE, for designing and ensuring a high-quality technological process – tabletting of API - Dapagliflozin propanediol monohydrate and excipients. To manage a critical technological parameter - the stability of the polymorphic structure of the API, which guarantees the quality of the tablet form, its bioavailability and bioequivalence, it is necessary to use a set of methods for studying structural changes and polymorphic modifications of the API during the tableting process. According to the results of the X-ray structural study of API and selected model compositions of tablets, it was established that during the process of tabletting under pressure, the structure of the polymorphic modification of dapagliflozin propanediol monohydrate does not change, and no polymorphic transition is observed
- Open Access
- 8 May 2024
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 3,p. 13-20
ASPECTS OF THE USE OF ANTIDIABETIC DRUGS IN PHARMACEUTICAL PRACTICE ON THE BASIS OF RATIONAL PHARMACOTHERAPY
The aim of the article. To study of the incidence of diabetes mellitus in Ukraine and to determine the prospects for the use and pharmaceutical development of antidiabetic drugs. Materials and methods. Data from the State Registers of Medicinal Products of Ukraine, of Wholesale and Retail Prices for Medicinal Products declared in Ukraine under an international non-proprietary or generic name (01.01.2024). Were used: systematic and comparative analysis, processing and synthesis, and generalization to determine the forecasted prospects. Results. In Ukraine the number of diabetes patients increased by 11% in the group of children and adolescents; in the group of elderly patients – by 12.5%, among the adult working – 20%, diabetes of the II type predominates. The trend of increase in the number of studies on the search for therapeutic alternatives for the treatment of type II diabetes and list of medicines on the pharmaceutical market has been revealed. In Ukraine drugs for oral use include APIs of the following pharmacological groups: sulfonylureas; meglitinides; biguanides; thiazolidinedione; α-glucosidase inhibitors; DPP-4 inhibitors; SGLT-2 inhibitors. Mechanism of action of the new class of oral hypoglycemic agents, approved by the FDA, consists in blocking SGLT-2 proteins from the proximal convoluted tubule in the kidney, leads to the prevention of reabsorption and excretion of the glucose molecule. This allows its use in combination with insulin and other antidiabetic drugs for the treatment of type I and II diabetes in patients of various age categories. According to the volume of clinical studies, SGLT-2 inhibitor SGLT-2 derivative gliflozin API drugs are the second largest group of antidiabetic drugs recommended for use by FDA and EMA regulatory bodies. Conclusions. The pharmaceutical development of mono and combined drugs with APIs SGLT-2 inhibitors gliflozin derivatives in combination with APIs with metformin, DPP-4 inhibitors, APIs thiazolidinedione derivatives is promising for solving the problem of diabetes treatment and prevention of complications for patients of different age groups including working population in Ukraine.
- 8 May 2024
- Published by State Institution of Science "Center of Innovative Healthcare Technologies" State Administrative Department in Clinical and Preventive Medicine
- No. 3,p. 13-20
Open AccessASPECTS OF THE USE OF ANTIDIABETIC DRUGS IN PHARMACEUTICAL PRACTICE ON THE BASIS OF RATIONAL PHARMACOTHERAPY
The aim of the article. To study of the incidence of diabetes mellitus in Ukraine and to determine the prospects for the use and pharmaceutical development of antidiabetic drugs. Materials and methods. Data from the State Registers of Medicinal Products of Ukraine, of Wholesale and Retail Prices for Medicinal Products declared in Ukraine under an international non-proprietary or generic name (01.01.2024). Were used: systematic and comparative analysis, processing and synthesis, and generalization to determine the forecasted prospects. Results. In Ukraine the number of diabetes patients increased by 11% in the group of children and adolescents; in the group of elderly patients – by 12.5%, among the adult working – 20%, diabetes of the II type predominates. The trend of increase in the number of studies on the search for therapeutic alternatives for the treatment of type II diabetes and list of medicines on the pharmaceutical market has been revealed. In Ukraine drugs for oral use include APIs of the following pharmacological groups: sulfonylureas; meglitinides; biguanides; thiazolidinedione; α-glucosidase inhibitors; DPP-4 inhibitors; SGLT-2 inhibitors. Mechanism of action of the new class of oral hypoglycemic agents, approved by the FDA, consists in blocking SGLT-2 proteins from the proximal convoluted tubule in the kidney, leads to the prevention of reabsorption and excretion of the glucose molecule. This allows its use in combination with insulin and other antidiabetic drugs for the treatment of type I and II diabetes in patients of various age categories. According to the volume of clinical studies, SGLT-2 inhibitor SGLT-2 derivative gliflozin API drugs are the second largest group of antidiabetic drugs recommended for use by FDA and EMA regulatory bodies. Conclusions. The pharmaceutical development of mono and combined drugs with APIs SGLT-2 inhibitors gliflozin derivatives in combination with APIs with metformin, DPP-4 inhibitors, APIs thiazolidinedione derivatives is promising for solving the problem of diabetes treatment and prevention of complications for patients of different age groups including working population in Ukraine.
- Open Access
- 29 March 2024
- Published by European Scientific Platform (Publications)
- No. March 29, ,p. 529-531
MANAGEMENT OF THE INNOVATIVE COMPONENT OF THE PHARMACEUTICAL DEVELOPMENT OF DRUGS AT THE LABORATORY STAGE IN THE PROFESSIONAL TRAINING OF MASTERS OF PHARMACY
Ensuring the improvement of the quality of training of modern masters of pharmacy in the system of university education, the transition to a qualitatively new level of professional training of students in the specialty 226 – "Pharmacy, industrial pharmacy", the educational – qualification level "Master" is carried out under the condition of modernization of its content, inclusion of students in active and voluntary process of formation of professional competence, creative development, which will allow to transform them from an object of training to a subject of activity.
- 29 March 2024
- Published by European Scientific Platform (Publications)
- No. March 29, ,p. 529-531
Open AccessMANAGEMENT OF THE INNOVATIVE COMPONENT OF THE PHARMACEUTICAL DEVELOPMENT OF DRUGS AT THE LABORATORY STAGE IN THE PROFESSIONAL TRAINING OF MASTERS OF PHARMACY
Ensuring the improvement of the quality of training of modern masters of pharmacy in the system of university education, the transition to a qualitatively new level of professional training of students in the specialty 226 – "Pharmacy, industrial pharmacy", the educational – qualification level "Master" is carried out under the condition of modernization of its content, inclusion of students in active and voluntary process of formation of professional competence, creative development, which will allow to transform them from an object of training to a subject of activity.
- Open Access
- 15 September 2023
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 31,p. 499-501
IMPLEMENTATION OF EUROPEAN REGULATORY EXPERIENCE AND MANAGEMENT OF THE PHARMACEUTICAL SECTOR OF THE HEALTH CARE INDUSTRY IN UNIVERSITY EDUCATION
The article is devoted to the implementation the experience of the pharmaceutical sector of the EU countries. The strategy of reforms of the pharmaceutical sector of the EU countries are being analyzed. Authors give their view to solving the problems, among them is the the development of a strategy to ensure the quality of training of masters of pharmacy in university education.
- 15 September 2023
- Published by European Scientific Platform (Publications) in Grail of Science
- No. 31,p. 499-501
Open AccessIMPLEMENTATION OF EUROPEAN REGULATORY EXPERIENCE AND MANAGEMENT OF THE PHARMACEUTICAL SECTOR OF THE HEALTH CARE INDUSTRY IN UNIVERSITY EDUCATION
The article is devoted to the implementation the experience of the pharmaceutical sector of the EU countries. The strategy of reforms of the pharmaceutical sector of the EU countries are being analyzed. Authors give their view to solving the problems, among them is the the development of a strategy to ensure the quality of training of masters of pharmacy in university education.
- Open Access
- 30 June 2023
- Published by Amazonia Investiga in Revista Amazonia Investiga
- Vol. 12 (65) , 29-38
Globalization of the education space in EU countries and Great Britain through radical information reform
The article reveals the main principles of globalization of the educational space in the EU countries and Great Britain through radical information reformation. The action plan, which includes the six dimensions disclosed in the article, is of great importance from 2020 to 2025 for the formation of the European Education Area (European Education Area), in the conditions of the COVID-19 pandemic and for the development of innovativeness. Measures developed by the European Commission to achieve the specified dimensions are proposed (increasing and monitoring the quality of education; paying attention to gender sensitivity and inclusiveness in education; modernizing digital transformations in education, increasing the competence and motivation of specialists involved in the educational field). The importance and necessity for the education of distance learning programs based on educational models that are known all over the world (in the example of Great Britain) is shown. In the field of information, constant changes and improvements are taking place, leading to the emergence of a qualitatively new type of social system. The information society is the main and necessary in the educational space, therefore the article shows the basic prerequisites of technological, spatial, economic, cultural, and political approaches to the improvement of the information society.
- 30 June 2023
- Published by Amazonia Investiga in Revista Amazonia Investiga
- Vol. 12 (65) , 29-38
Open AccessGlobalization of the education space in EU countries and Great Britain through radical information reform
The article reveals the main principles of globalization of the educational space in the EU countries and Great Britain through radical information reformation. The action plan, which includes the six dimensions disclosed in the article, is of great importance from 2020 to 2025 for the formation of the European Education Area (European Education Area), in the conditions of the COVID-19 pandemic and for the development of innovativeness. Measures developed by the European Commission to achieve the specified dimensions are proposed (increasing and monitoring the quality of education; paying attention to gender sensitivity and inclusiveness in education; modernizing digital transformations in education, increasing the competence and motivation of specialists involved in the educational field). The importance and necessity for the education of distance learning programs based on educational models that are known all over the world (in the example of Great Britain) is shown. In the field of information, constant changes and improvements are taking place, leading to the emergence of a qualitatively new type of social system. The information society is the main and necessary in the educational space, therefore the article shows the basic prerequisites of technological, spatial, economic, cultural, and political approaches to the improvement of the information society.